Lundbeck Research USA is a subsidiary of Denmark-based H. Lundbeck A/S. H. Lundbeck A/S has partnered with other US pharmaceutical companies to bring valuable products to patients with CNS disorders. Currently, they are partnering with the following companies to market drugs in the US:
 |
Forest Laboratories, Inc.
Forest markets escitalopram under the Lexapro® brand name in the US. US sales of Lexapro totaled $2.1 Billion in 2005 according to IMS Health. It is marketed by H. Lundbeck A/S and its subsidiaries in other countries as well.  A majority of Latin American, Australian and Asian markets also use the Lexapro brand name, whereas some of the significant markets in Europe use the Cipralex®/Seroplex®/Sipralex® brand names. |
|
